Neoantigen-specific T-cell response after donor lymphocyte infusion associates with favorable outcome in a patient with i(12p) germ cell tumor, acute leukemia and sarcoma of the same clonal origin
Vassilis Genoud,
Valérie Dutoit,
Nhu-Nam Tran Thang,
Andrew Janowczyk,
Thomas McKee,
Yves Chalandon,
Petros Tsantoulis,
Pierre-Yves Dietrich
Affiliations
Vassilis Genoud
Departement of oncology, Geneva University Hospital, Geneva
Valérie Dutoit
Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman
Nhu-Nam Tran Thang
Departement of oncology, Geneva University Hospital, Geneva
Andrew Janowczyk
SIB Swiss Institute of Bioinformatics
Thomas McKee
Swiss Cancer Centre Léman, Switzerland; Clinical Pathology Service, Geneva University Hospital, Geneva
Yves Chalandon
Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Swiss Cancer Centre Léman
Petros Tsantoulis
Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Swiss Cancer Centre Léman
Pierre-Yves Dietrich
Departement of oncology, Geneva University Hospital, Geneva, Switzerland; Laboratory of tumor immunology, Faculty of Medicine and Centre for Translational Research in Onco-Hematology, University of Geneva, Switzerland; Swiss Cancer Centre Léman
